2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow SARS-CoV-2: new trials by email Literature Review of SARS-CoV-2 trials Research Report on SARS-CoV-2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease Valsartan (Diovan), Placebo oral tablet - Acute Respiratory Distress Syndrome, SARS-CoV-2 | Phase 4 | Terminated | Radboud University Medical Center | 23 | 2020-04-17 | 2021-09-24 |
| Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds Hydroxychloroquine Sulfate Regular dose, Hydroxychloroquine Sulfate Loading Dose, Chloroquine - SARS-CoV-2, Coronavirus Infection | Phase 4 | Terminated | Government of Punjab, Specialized Healthcare and Medical Education Department | 125 | 2020-04-14 | 2021-03-10 |
COVID-19 (2) · Asymptomatic Diseases (1) · Coronavirus Infections (1) · Respiratory Distress Syndrome (1) · Severe Acute Respiratory Syndrome (1)
Coronaviridae Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Coronavirus Infections (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1)
Chloroquine (1) · Valsartan (1)
Government of Punjab, Specialized Healthcare and Medical Education Department (1) · Radboud University Medical Center (1)
Netherlands (1) · Pakistan (1)